Look for a durable, lightweight, water-resistant backpack with padded straps and multiple compartments. Leave your roller ...
Summit Therapeutics has revealed that a second pivotal trial of its Akeso-partnered PD-1xVEGF bispecific ivonescimab has failed to show an improvement in overall survival in a lung cancer trial. New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback